Гистологическая и иммуногистохимическая характеристика менингиом головного мозга
https://doi.org/10.12737/23031
Аннотация
Ключевые слова
Об авторах
В. А. БывальцевРоссия
В. А. Сороковиков
Россия
И. А. Степанов
Россия
С. Л. Антипина
Россия
Список литературы
1. Батороев Ю.К., Шапиро Н.А., Дворниченко В.В. Цитологическая диагностика опухолей нервной системы: цветной атлас. - М. - Иркутск, 2008. - 150 с
2. Бывальцев В.А., Степанов И.А., Белых Е.Г. Биология менингеальных опухолей головного мозга // Сибирский медицинский журнал. - 2015. - № 3. - C. 15-19
3. Древаль О.Н. Нейрохирургия: руководство для врачей. - М.: Литерра, 2012. - 592 с
4. Artlich A, Schmidt D (2007). Immunohistochemical profile of meningiomas and their histological subtypes. Hum Pathol, 21, 843-849.
5. Carroll RS, Glowacka D, Dashner K, Black PM (2013). Progesterone receptor expression in meningiomas. Cancer Res, 53, 1312-1326.
6. Couce ME, Aker FV, Scheithauer BW (2000). Chordoid meningioma: a clinicopathologic study of 42 cases. Am J Surg Pathol, 24: 899-905.
7. Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A (2006). NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathol, 16, 15-19.
8. Hsu DW, Efird JT, Hedley-Whyte ET (2007). Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg, 86, 113-120.
9. Kepes JJ, Moral LA, Wilkinson SB, Abdullah A, Llena JF (1998). Rhabdoid transformation of tumor cells in meningiomas: a histologic indication of increased proliferative activity: report of four cases. Am J Surg Pathol, 22, 231-238.
10. Kleihues P, Cavenee WK (2000). International Agency for Research on Cancer. Pathology and genetics of tumors of the nervous system. Lyon: IARC Press.
11. Ludwin SK, Rubinstein LJ, Russell DS (1975). Papillary meningioma: a malignant variant of meningioma. Cancer, 36, 1363-1373.
12. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M (2011). Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol, 25, 472-478.
13. Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens A, Couderc P (1986). Papillary meningioma: clinicopathologic study of seven cases and review of the literature. Cancer, 58, 299-305.
14. Paulus W, Meixensberger J, Hofmann E, Roggendorf W (1993). Effect of embolisation of meningioma on Ki-67 proliferation index. J Clin Pathol, 46, 876-877.
15. Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH (2010). Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol, 59, 872-79.
16. Perry A, Scheithauer BW, Stafford SL, Abell-Aleff PC, Meyer FB (1998). "Rhabdoid" meningioma: an aggressive variant. Am J Surg Pathol, 22, 1482-1490.
17. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (2005). "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer, 85, 2046-2056.
18. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997). Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol, 21, 1455-1465.
19. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998). The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer, 82, 2262-2269.
20. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN (2014). The mitosis-specific antibody anti-phos-phohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol, 28, 1532-1536.
21. Schnitt SJ, Vogel H (1996). Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol, 10, 640-649.
22. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997). Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA, 94, 14719-14724.
23. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1996). Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol, 146, 827-832.
24. Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB (1995). Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol, 19, 493-505.
Рецензия
Для цитирования:
Бывальцев В.А., Сороковиков В.А., Степанов И.А., Антипина С.Л. Гистологическая и иммуногистохимическая характеристика менингиом головного мозга. Acta Biomedica Scientifica. 2016;1(4):187-194. https://doi.org/10.12737/23031
For citation:
Byvaltsev V.A., Sorokovikov V.A., Stepanov I.A., Antipina S.L. Histological and immunohistochemical characteristics of brain meningiomas. Acta Biomedica Scientifica. 2016;1(4):187-194. (In Russ.) https://doi.org/10.12737/23031